The activation of MYC target gene signatures is also present in SCCOHT tumors [23], and in BRG1-null lung cancer cell lines, the reintroduction of BRG1 antagonizes MYC function [24], pointing to a connection between BRG1 and MYC that may resemble that of SNF5. Here, SMARCA4 is linked to lung cancer.